Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Budesonide-Formoterol in Bronchiectasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-80 years old patients diagnosed of non-cystic fibrosis bronchiectasis~* More than 1 pulmonary lobe affected~* Chronic obstructive airflow obstruction~* Stable phase of the disease~Exclusion Criteria:~* Asthma, COPD or current/past smnokers~* No consent~* Known intolerance to budesonide or formoterol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Medium Dose of budesonide-formoterol
- B (Type: ACTIVE_COMPARATOR): High dose of inhaled budesonide (1600 mcg/day)

Based on this trial design, predict the completion outcome and termination type (if applicable).